BOSTON--(BUSINESS WIRE)--Predicta Biosciences, a precision oncology company developing novel diagnostic and therapeutic products, today announced it has raised an oversubscribed $5.2 million seed ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Predicta Biosciences, a precision oncology company developing novel diagnostic and therapeutic products, today announced the availability of its first Laboratory ...
When you see a ventriloquist like [Jeff Dunham], you probably expect to see him with a puppet. This time – spoilers ahead – you won’t. Besides his fame on stage, [Dunham] is also a collector of ...
CAMBRIDGE, Mass., October 01, 2025--(BUSINESS WIRE)--Predicta Biosciences, a precision oncology company developing novel diagnostic and therapeutic discovery solutions, today announced it has raised ...
When you see a ventriloquist like [Jeff Dunham], you probably expect to see him with a puppet. This time – spoilers ahead – you won’t. Besides his fame on stage, [Dunham] is also a collector of ...
Predicta is expanding to the US and opening offices in Silicon Valley, the decade-old Brazilian B2B tech company announced today. As you may remember, it first announced these plans last December in ...
Brian McKernan joins as CEO to further advance Predicta’s clinical impact, including its non-invasive diagnostic for Multiple Myeloma “It’s an honor to join Predicta and our strong team of leading ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback